ETFs
A
ALNY
Alnylam Pharmaceuticals Inc
297.45
-3.06-1.02%After Hours: 298.14 +0.69 +0.23%19:29 05/22 EDT
OPEN/PREV CLOSE299.12/300.51
TODAY RANGE294.99-303.33
VOL681.31K
MARKET CAP39.71B
52 WEEK RANGE284.19-495.55
AVG VOL (3M)1.09M
% TURNOVER0.51%
TURNOVER--
P/E (TTM)70.85
% RANGE2.78%
EPS(TTM)4.198
P/E(FORWARD)42.25
P/B36.91
BVPS8.06
DIVIDEND--
P/S10.60
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP39.60B
SHARES OUTSTANDING133.51M
NEXT EARNINGS07/29-08/03
FREE FLOAT133.15M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·1h ago
Assessing Alnylam Pharmaceuticals (ALNY) Valuation After Mixed Share Performance And Strong AMVUTTRA Uptake
Seeking Alpha·1d ago
These Are The Upcoming Catalysts For Crispr Therapeutics Stock
Seeking Alpha·3d ago
Ionis, Alnylam, BioMarin up as Citi starts at Buy on catalyst and growth outlook
NASDAQ·4d ago
IBB, GILD, REGN, ALNY: ETF Outflow Alert
Dow Jones·4d ago
Alnylam Pharmaceuticals Initiated at Buy by Citigroup
Simply Wall St·4d ago
How HELIOS-B Phase 3 Vutrisiran Data and Real-World Evidence Expansion Will Impact Alnylam (ALNY) Investors
TipRanks·4d ago
Alnylam initiated with a Buy at Citi
Same Industry
Name/Symbol
Change%
Price